about
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune,...
Read More
1.27
0.04
(3.25%)
399.1K
XNAS Volume
XNAS 07 Apr, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
INmune Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..